Overall, this study provides a mechanistic basis for the application of HKDC1 as a potential therapeutic target in advanced liver cancer, and provides new ideas for the treatment of tumor patients (Yu & Bao, 2023). This evidence concerns the gene HKDC1 and neoplasm.